22 June 2015
Researchers have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory Syndrome. Planning for the first clinical trial is now underway.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/x4hmzwZ0mkQ/150622071228.htm
